← Back to Search

Healthy subjects for Left Ventricular Hypertrophy

N/A
Recruiting
Led By Michael Koren, MD
Research Sponsored by Prolaio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.

Eligible Conditions
  • Left Ventricular Hypertrophy
  • Hypertrophic Cardiomyopathy
  • Heart Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

4Treatment groups
Experimental Treatment
Group I: Subjects with a history of hypertrophic cardiomyopathy NYHA Class I, IIExperimental Treatment1 Intervention
Group II: Healthy subjectsExperimental Treatment1 Intervention
Group III: Asymptomatic subjects with a history of HFExperimental Treatment1 Intervention
Group IV: Asymptomatic left ventricular hypertrophyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Software
2009
N/A
~20

Find a Location

Who is running the clinical trial?

ProlaioLead Sponsor
1 Previous Clinical Trials
400 Total Patients Enrolled
Michael Koren, MDPrincipal InvestigatorJacksonville Center For Clinical Research
2 Previous Clinical Trials
170 Total Patients Enrolled
~35 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top